TERAWULF INC (WULF) Fundamental Analysis & Valuation

NASDAQ:WULF • US88080T1043

Current stock price

20.64 USD
+1.33 (+6.89%)
At close:
20.58 USD
-0.06 (-0.29%)
After Hours:

This WULF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. WULF Profitability Analysis

1.1 Basic Checks

  • WULF had negative earnings in the past year.
  • WULF had a negative operating cash flow in the past year.
  • In the past 5 years WULF always reported negative net income.
  • WULF had negative operating cash flow in 4 of the past 5 years.
WULF Yearly Net Income VS EBIT VS OCF VS FCFWULF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -10.09%, WULF is doing worse than 63.97% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -470.94%, WULF is doing worse than 86.03% of the companies in the same industry.
Industry RankSector Rank
ROA -10.09%
ROE -470.94%
ROIC N/A
ROA(3y)-12.9%
ROA(5y)-20.6%
ROE(3y)-177.86%
ROE(5y)-137.52%
ROIC(3y)N/A
ROIC(5y)N/A
WULF Yearly ROA, ROE, ROICWULF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • WULF has a worse Gross Margin (50.93%) than 69.12% of its industry peers.
  • WULF's Gross Margin has improved in the last couple of years.
  • WULF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.67%
GM growth 5Y11.83%
WULF Yearly Profit, Operating, Gross MarginsWULF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. WULF Health Analysis

2.1 Basic Checks

  • WULF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WULF has been increased compared to 1 year ago.
  • WULF has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for WULF is higher compared to a year ago.
WULF Yearly Shares OutstandingWULF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
WULF Yearly Total Debt VS Total AssetsWULF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • WULF has an Altman-Z score of 0.86. This is a bad value and indicates that WULF is not financially healthy and even has some risk of bankruptcy.
  • WULF's Altman-Z score of 0.86 is on the low side compared to the rest of the industry. WULF is outperformed by 63.60% of its industry peers.
  • A Debt/Equity ratio of 33.00 is on the high side and indicates that WULF has dependencies on debt financing.
  • WULF has a Debt to Equity ratio of 33.00. This is amonst the worse of the industry: WULF underperforms 86.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 33
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC9.24%
WULF Yearly LT Debt VS Equity VS FCFWULF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B 4B

2.3 Liquidity

  • WULF has a Current Ratio of 2.00. This indicates that WULF is financially healthy and has no problem in meeting its short term obligations.
  • WULF has a Current ratio of 2.00. This is comparable to the rest of the industry: WULF outperforms 58.46% of its industry peers.
  • WULF has a Quick Ratio of 2.00. This indicates that WULF is financially healthy and has no problem in meeting its short term obligations.
  • WULF has a Quick ratio (2.00) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
WULF Yearly Current Assets VS Current LiabilitesWULF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. WULF Growth Analysis

3.1 Past

  • The earnings per share for WULF have decreased strongly by -205.26% in the last year.
  • WULF shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.28%.
  • Measured over the past years, WULF shows a very strong growth in Revenue. The Revenue has been growing by 65.84% on average per year.
EPS 1Y (TTM)-205.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
Revenue 1Y (TTM)20.28%
Revenue growth 3Y123.79%
Revenue growth 5Y65.84%
Sales Q2Q%2.43%

3.2 Future

  • WULF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.43% yearly.
  • The Revenue is expected to grow by 75.74% on average over the next years. This is a very strong growth
EPS Next Y-51.29%
EPS Next 2Y40.97%
EPS Next 3Y25.44%
EPS Next 5Y36.43%
Revenue Next Year110.61%
Revenue Next 2Y135.14%
Revenue Next 3Y93.97%
Revenue Next 5Y75.74%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
WULF Yearly Revenue VS EstimatesWULF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
WULF Yearly EPS VS EstimatesWULF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. WULF Valuation Analysis

4.1 Price/Earnings Ratio

  • WULF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year WULF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WULF Price Earnings VS Forward Price EarningsWULF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WULF Per share dataWULF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

  • WULF's earnings are expected to grow with 25.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.97%
EPS Next 3Y25.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WULF Dividend Analysis

5.1 Amount

  • No dividends for WULF!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WULF Fundamentals: All Metrics, Ratios and Statistics

TERAWULF INC

NASDAQ:WULF (4/17/2026, 8:00:02 PM)

After market: 20.58 -0.06 (-0.29%)

20.64

+1.33 (+6.89%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners78.51%
Inst Owner Change0.37%
Ins Owners6.58%
Ins Owner Change-0.35%
Market Cap8.75B
Revenue(TTM)168.46M
Net Income(TTM)-661.42M
Analysts83
Price Target25.37 (22.92%)
Short Float %31.57%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-73.76%
Min EPS beat(2)-108.29%
Max EPS beat(2)-39.24%
EPS beat(4)1
Avg EPS beat(4)-64.35%
Min EPS beat(4)-133.63%
Max EPS beat(4)23.75%
EPS beat(8)1
Avg EPS beat(8)-89.41%
EPS beat(12)1
Avg EPS beat(12)-104.78%
EPS beat(16)2
Avg EPS beat(16)-145.05%
Revenue beat(2)0
Avg Revenue beat(2)-14.36%
Min Revenue beat(2)-23.26%
Max Revenue beat(2)-5.47%
Revenue beat(4)1
Avg Revenue beat(4)-12.39%
Min Revenue beat(4)-23.26%
Max Revenue beat(4)0.98%
Revenue beat(8)1
Avg Revenue beat(8)-11.61%
Revenue beat(12)1
Avg Revenue beat(12)-12.39%
Revenue beat(16)2
Avg Revenue beat(16)-27.04%
PT rev (1m)7.07%
PT rev (3m)12.19%
EPS NQ rev (1m)-24.27%
EPS NQ rev (3m)-51.71%
EPS NY rev (1m)-88.28%
EPS NY rev (3m)-170.73%
Revenue NQ rev (1m)-10.05%
Revenue NQ rev (3m)-37.17%
Revenue NY rev (1m)1.29%
Revenue NY rev (3m)-3.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 51.96
P/FCF N/A
P/OCF N/A
P/B 62.32
P/tB 102.99
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)-2.79
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.4
BVpS0.33
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -10.09%
ROE -470.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.93%
FCFM N/A
ROA(3y)-12.9%
ROA(5y)-20.6%
ROE(3y)-177.86%
ROE(5y)-137.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.67%
GM growth 5Y11.83%
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1196.64%
Cap/Sales 629.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 0.86
F-Score2
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)636.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)309.75%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
EPS Next Y-51.29%
EPS Next 2Y40.97%
EPS Next 3Y25.44%
EPS Next 5Y36.43%
Revenue 1Y (TTM)20.28%
Revenue growth 3Y123.79%
Revenue growth 5Y65.84%
Sales Q2Q%2.43%
Revenue Next Year110.61%
Revenue Next 2Y135.14%
Revenue Next 3Y93.97%
Revenue Next 5Y75.74%
EBIT growth 1Y-186.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year243.1%
EBIT Next 3Y125.57%
EBIT Next 5Y80.82%
FCF growth 1Y-304.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-404.38%
OCF growth 3YN/A
OCF growth 5YN/A

TERAWULF INC / WULF Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TERAWULF INC (WULF) stock?

ChartMill assigns a fundamental rating of 3 / 10 to WULF.


Can you provide the valuation status for TERAWULF INC?

ChartMill assigns a valuation rating of 1 / 10 to TERAWULF INC (WULF). This can be considered as Overvalued.


How profitable is TERAWULF INC (WULF) stock?

TERAWULF INC (WULF) has a profitability rating of 1 / 10.


Can you provide the financial health for WULF stock?

The financial health rating of TERAWULF INC (WULF) is 2 / 10.


Can you provide the dividend sustainability for WULF stock?

The dividend rating of TERAWULF INC (WULF) is 0 / 10 and the dividend payout ratio is 0%.